Europe's top biotech expects delays from drugs watchdog's HQ move

LONDON (Reuters) – Europe’s biggest biotechnology company, Denmark’s Genmab, expects some delays to regional drug approvals as the European Medicines Agency is uprooted from London to Amsterdam.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *